Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics
December 15, 2014 at 09:01 AM EST
Baxter International Inc. (NYSE: BAX) today announced that it has entered into a definitive agreement to sell its proprietary Vero cell ...